ESTA | Ticker Profile - Titan Protect

ESTA

Establishment Labs Holdings Inc.

Healthcare · Medical Devices · NCM

$74.31

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$2.1B

Total market value of the company

Trailing P/E

N/A

Forward P/E

950.93

Based on estimated future earnings — lower means cheaper

Rev Growth

+44.7%

Year-over-year revenue change

Profit Margin

-19.1%

How much profit the company keeps from each dollar of revenue

ROE

-164.0%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$90.00

+21% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 9 analysts covering this stock

About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

https://www.establishmentlabs.com

Country: United States Employees: 1,004 Industry: Medical Devices

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.599

Good returns relative to risk taken

Kelly Fraction

0.0450

Modest edge detected — smaller position warranted

Calmar Ratio

0.383

Drawdown risk outweighs the returns — higher risk profile

Annual Return

18.9%

Historical annualised return based on price data

Max Drawdown

-49.3%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

119

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.12

Moves slightly more than the broader market

52W High

$83.31

11% below the year high

52W Low

$33.35

123% above the year low

Avg Volume

496,368

Average daily shares traded — higher means easier to buy and sell

Short Ratio

6.7

Days it would take all short sellers to cover — higher means more crowded

Short % Float

15.6%

Elevated short interest — bears are positioned against this

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-1.47

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

1,785.54

Heavy leverage — higher financial risk if revenues decline

Current Ratio

2.96

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

1.75

Like current ratio but excludes inventory — stricter test

Gross Margin

70.1%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-10.9%

Profit from core operations before interest and tax

Free Cash Flow

$-27,834,000

Negative — the business is spending more than it generates

Revenue (TTM)

$230M

Total revenue over the last 12 months

Net Income

$-43,736,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$100.00

Target Median

$90.00

Target Low

$76.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
9 Apr2026	Josh Gottheimer	Democrat	sell	15K–50K
6 Apr2026	Josh Gottheimer	Democrat	buy	1K–15K
2026-04-09	Josh Gottheimer	Democrat	Sale	15K–50K
2026-04-06	Josh Gottheimer	Democrat	Purchase	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go